We investigated the role of SHPS-1/SIRPa1 in IL-1b-and TNFa-dependent signaling that leads to the activation of Erk 1/2 and Akt. Treatment of Balb3T3 cells with IL-1b or TNFa activated tyrosine phosphorylation of SHPS-1, its association with SHP-2 and the phosphorylation of Erk 1/2 and Akt. PP1, a specific inhibitor for the Src family protein tyrosine kinases, strongly inhibited tyrosine phosphorylation of SHPS-1 and complex formation of SHPS-1 with SHP-2 by IL1b. In addition, PP1 substantially inhibited the IL-2b-and TNFa-dependent activation of Erk 1/2 and Akt. Exogenous expression of either SHPS-1 mutants that lack SHP-2 binding function or a dominant negative mutant of SHP-2 markedly inhibited the activation of Erk 1/2 and Akt by IL-1b, whereas wild type SHPS-1 did not. Moreover, IL-1b-stimulation induced association of SHPS-1 with IL-1RAcP, a second subunit of IL-1 receptor, whereas expression of SHPS-1 mutant that lack SHP-2 binding function clearly blocked the association and tyrosine phosphorylation of endogenous SHPS-1. Taken together, our results strongly suggest that activation of Erk 1/2 and Akt by proinflammatory cytokines requires tyrosine phosphorylation of SHPS-1 and subsequent association of SHPS-1 with SHP-2.
Interleukin-1 (IL-1) and tumor necrosis factor (TNF) are proinflammatory cytokines that activate cell proliferation and play an important role in local and systemic immune responses (Dinarello and Wolff, 1993; Dinarello, 1994 Dinarello, , 1996 Kampschmidt, 1984; BankersFulbright et al., 1996) . Despite the importance, the molecular mechanism by which these cytokines induce cellular response is not completely understood. Both IL-1 and TNF have two types of receptors (BankersFulbright et al., 1996; Tartaglia and Goeddel, 1992) , but none of them has intrinsic kinase activity, suggesting that their signal must be transmitted into cells by their accessory molecules. Down-stream of the receptor, both of these cytokines can activate multiple signaling pathways. One of the prominent signaling pathways is the MEK1 -MAPK cascade that regulates cell proliferation (Yang et al., 2000) . Another prominent one is the Akt pathway that seems to be important for the NF-kB activation (Sizemore et al., 1999; Ozes et al., 1999) . In addition to Akt, SHP-2, a cytoplasmic tyrosine phosphatase containing SH2 domain (Freeman et al., 1992; Adachi et al., 1992) , appears to modulate the NF-kB pathway (You et al., 2001) . Although both the MEK1 -MAPK and the Akt-NF-kB pathways are critical for IL-1 and TNFa signaling, how they are activated remains to be explored.
In response to ligand stimulation such as insulin and brain derived neurotrophic factor (BDNF), SHP-2 binds with a glycoprotein named SHPS-1, which is also known as SIRPa1, BIT or p84. SHPS-1 has four YXX (L/V/I) motifs in the cytoplasmic region those serve as binding sites for SHP-1/2 . In cells overexpressing wild type SHPS-1, both insulin-dependent activation of MAPK and BDNF-promoted neuronal survival via the PI3K-Akt pathway (Araki et al., 2000) were enhanced, whereas overexpression of mutant SHPS-1 lacking SHP-2 binding sites inhibited the MAPK activation by LPA . In contrast, overexpression of SIRPa1/SHPS-1 in NIH3T3 cells inhibited DNA synthesis and activation of MAPK by epidermal growth factor (EGF) and insulin or PI3K by EGFR (Kharitonenkov et al., 1997; Wu et al., 2000) . Although these results suggest the importance of SHPS-1 in SHP-2-dependent signaling, it is still inconclusive and SHPS-1 signaling seems to yield opposing effects depending on the types of ligands and cells. Moreover, molecular linkage between receptors and SHPS-1 remains unclear in these studies. In addition, all these studies focused on the growth factor signaling and the role of SHPS-1 in cytokinedependent signaling remains to be studied.
In this paper, we show that stimulation of cells with IL-1b or TNFa induces tyrosine phosphorylation of SHPS-1 and subsequent binding of SHPS-1 with SHP-2 in a Src kinase-dependent manner. We provide evidence that SHPS-1-SHP-2 complex formation by IL-1b stimulation is required for the activation of the dual signaling pathways, MEK1 -MAPK and PI3K-Akt. Furthermore, we show for the first time that SHPS-1 forms a complex with IL-1RAcP, a second subunit of IL-1 receptor, by IL-1b stimulation and mutant form of SHPS-1 can block the complex formation.
We first examined the activation of MAPK (Erk 1/2) and Akt by stimulation with IL-1b or TNFa in a mouse fibroblast cell line, Balb3T3. As shown in Figure  1 (a -d) , treatment of cells with IL-1b or TNFa substantially activated the phosphorylation of MAPK and Akt in a time-dependent manner. Both of them showed phosphorylation within 5 min of stimulation and formed a peak at 15 min. Under these conditions, we examined tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Cell lysates from IL-1b-or TNFa-stimulated Balb3T3 were immunoprecipitated Figure 1 IL-1b and TNFa induce tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Balb3T3 cells were serumstarved for overnight and stimulated with 1 nM IL-1b or TNFa for the indicated time period or 15 min if not indicated. Cell lysates for immunoblotting, immunoprecipitation and co-precipitation were prepared as described Wong et al., 1999) . Immunoblotting and immunoprecipitation were performed as described previously (Hamaguchi et al., 1993) . (a -d) Upper panels, total cell lysates were subjected to SDS -PAGE and immunoblotted with anti-phospho-Erk (a,b) or anti-phospho-Akt (c,d); lower panels, same membranes were subsequently reprobed with anti-Erk-2 (a,b) or anti-Akt (c,d) as described previously . (e,f) Proteins were immunoprecipitated with anti-SHPS-1 and immunoblotted with anti-phosphotyrosine (upper panels). Same membranes were reprobed with anti-SHPS-1 (lower panels). (g,h) Upper panels, anti-SHPS-1 immunoprecipitates were immunoblotted with anti-SHP-2 (g) or anti-Src (h); lower panels, same membranes were reprobed with anti-SHPS-1 with anti-SHPS-1 and the immunoprecipitates were probed with anti-phosphotyrosine antibody. As shown in Figure 1e ,f, both IL-1b and TNFa activated tyrosine phosphorylation of SHPS-1 within 15 -30 min that coincided with the phosphorylation of MAPK and Akt. When these anti-SHPS-1 immunoprecipitates were probed with anti-SHP-2, SHP-2 protein became clearly detectable after IL-1b and TNFa stimulation and followed a time course similar to those of SHPS-1 phosphorylation and activation of Erk and Akt, suggesting that both IL-1b and TNFa activate complex formation of SHPS-1 with SHP-2 ( Figure 1g ). In contrast to SHP-2, SHPS-1 did not form a stable complex with Src by IL-1b stimulation (Figure 1h ) or SHP-1 (data not shown), although Src and SHP-1 also contain SH-2 domains. These results suggest that IL-1b-dependent complex formation of SHPS-1 is specific for a particular set of proteins.
We next examined the effect of PP1, a potent inhibitor for the Src family kinase, on phosphorylation of SHPS-1 and its complex formation with SHP-2. Tyrosine phosphorylation of SHPS-1 by IL-1b stimulation was substantially blocked by pretreatment of cells with PP1 (Figure 2a) , suggesting the involvement of the Src family kinase in IL-1b-dependent phosphorylation of SHPS-1. Moreover, PP1 could block the complex formation of SHPS-1 with SHP-2 (Figure 2b ), suggesting that tyrosine phosphorylation of SHPS-1 by the Src family kinase is required for the complex formation. Pretreatment of cells with PP1 also suppressed the phosphorylation of MAPK and Akt by IL-1b and TNFa (Figure 2c -f) . These results suggest the importance of the Src family kinase in proinflammatory cytokine signaling.
To investigate the role of complex formation of SHPS-1 with SHP-2 in IL-1b-dependent signaling, we generated two types of mutant SHPS-1. In the mutant YF4, all of the tyrosine residues in the cytoplasmic domain of SHPS-1, critical for the SHP-2 binding, were replaced with phenylalanine. In another mutant ECTM, the cytoplasmic domain of SHPS-1 was deleted. Both of the mutants as well as the wild type SHPS-1 were myc-tagged and expressed in COS7 cells (Figure 3a) . Tyrosine phosphorylation of these SHPS-1 proteins was examined by immunoprecipitation with anti-Myc antibody. IL-1b stimulation induced efficient tyrosine phosphorylation of the wild type SHPS-1, whereas no phosphorylated bands were detected in the SHPS-1 mutants (Figure 3b ). Moreover, a tyrosine phosphorylated protein corresponding to SHP-2 was co-precipitated with SHPS-1 only in the wild type, but not in the mutant cells, suggesting the critical role of the tyrosine residues of SHPS-1 for the complex formation with SHP-2. IL-1b-dependent phosphorylation of MAPK and Akt were also suppressed in these cells expressing SHPS-1 mutants (Figure 3c,d) .
To confirm and extend these observations, we stably expressed the wild type and the ECTM mutant in Balb3T3 cells (Figure 3e ). Cells expressing ECTM mutant had similar level of SHPS-1 compared with parental Balb3T3 (Figure 3e,f) . However, IL-1b- SHPS-1/SIRPa1 in IL-1b-and TNFa-dependent signaling ARM Ruhul Amin et al dependent phosphorylation of SHPS-1 was strongly suppressed in the ECTM-expressing cells (Figure 3f ). In addition, basal level phosphorylation of SHPS-1 in the mutant cells was lower than the parental cells. These results suggest that ECTM mutant has a dominant-inhibitory effect on the phosphorylation of endogenous SHPS-1. In cells overexpressing the ECTM mutant, but not the wild type SHPS-1, we found that IL-1b-dependent phosphorylation of MAPK and Akt was strongly suppressed (Figure 3g,h) , presumably due to the dominant-negative effect of ECTM mutant on the endogenous SHPS-1. These results again strongly suggest the importance of SHPS-1 phosphorylation in the activation of MAPK and Akt by IL-1b.
Together with the complex formation, IL-1b stimulation activated the tyrosine phosphorylation of SHP-2 (Figure 4a ). Pretreatment of Balb3T3 cells with PP1 could inhibit the IL-1b-dependent phosphorylation of SHP-2, suggesting the involvement of the Src family kinase as an upstream moderator of SHP-2. In addition, pretreatment of Balb3T3 cells with sodium orthovanadate, an inhibitor for protein tyrosine phosphatases, markedly (*65%) inhibited IL-1b-induced phosphorylation of MAPK and Akt (Figure (e -h) Balb3T3 were stably transfected with wild type and ECTM mutant of SHPS-1 and clones were selected as described previously (Thant et al., 1999) . (e) Expression of the SHPS-1 constructs in Balb3T3. Total cell lysates were immunoblotted with anti-Myc (upper panel) and with anti-SHPS-1 (lower panel). (f) Anti-SHPS-1 immunoprecipitates were probed with anti-phosphotyrosine (upper panel) and reprobed with anti-SHPS-1 (lower panel). (g,h) Total cell lysates were prepared from IL-1b treated and untreated cells and separated by SDS -PAGE. Upper panels, membranes were probed with anti-phospho-Erk (g) or anti-phospho-Akt (h); lower panels, same membranes were reprobed with antiErk-2 (g) and anti-Akt (h) 4b,c). These results suggest the involvement of tyrosine phosphatase in IL-1b-dependent activation of MAPK and Akt.
To confirm and investigate further the role of SHP-2 in IL-1b-dependent signaling, we transiently expressed the wild type and a catalytically inactive (dominant negative) mutant of SHP-2, CS (C463S), in COS7 cells (Figure 4d ). Both of them were HA-tagged. Interestingly, exogenous expression of CS-SHP-2 strongly inhibited the phosphorylation of MAPK and Akt by IL-1b (Figure 4e,f) , whereas cells expressing vector alone or the wild type SHP-2 showed no inhibition. These results suggest the involvement of SHP-2 in IL1b-dependent activation of MAPK and Akt.
Although various types of stimuli appear to activate the tyrosine phosphorylation of SHPS-1, how receptor signaling links with SHPS-1 signaling is not yet clarified Araki et al., 2000; Takeda et al., 1998; Kharitonenkov et al., 1997; Wu et al., 2000) . To address this important question, we investigated the interaction between IL-1 receptor signaling and SHPS-1 in Balb3T3 cells and Balb3T3 overexpressing the ECTM mutant. As shown in Figure  4g , we found that IL-1b stimulation induced association of SHPS-1 with IL-1RAcP, which is a second subunit of IL-1RI essential for IL-1 signaling (Cullinan et al., 1998) . In addition, in cells overexpressing the ECTM mutant, this IL-1b-dependent complex forma- tion between SHPS-1 and IL-1RAcP was substantially inhibited, further suggesting that ECTM mutant has dominant-inhibitory effect on IL-1b signaling.
In this study, we provided evidence for the role of SHPS-1, acting via one of its adaptor proteins, SHP-2, as a critical positive component in IL-1b signaling leading to MAPK and Akt activation. Proinflammatory cytokines, IL-1b and TNFa, regulate various cell functions including growth, survival and immune response through the MEK1-MAPK and the PI3K-Akt pathways (Dinarello and Wolff, 1993; Dinarello, 1994 Dinarello, , 1996 Bankers-Fulbright et al., 1996; Yang et al., 2000; Sizemore et al., 1999; Madge and Pober, 2000) . Although the signaling elements proximal to MAPK and Akt have been extensively studied (BankersFulbright et al., 1996; Yang et al., 2000; Sizemore et al., 1999; Ozes et al., 1999) , linkage of these elements with signaling molecules proximal to the receptor still remains unknown. We propose SHPS-1 as the key signaling intermediate that links the dual signaling pathway, MEK1 -MAPK and Akt-NF-kB, with the upstream proinflammatory cytokine-dependent signaling molecules. We have shown that after the stimulation of cells with IL-1b or TNFa, SHPS-1 is tyrosine phosphorylated, triggering the recruitment of SHP-2 at the vicinity of the cell membrane by forming a complex with it, together with the tyrosine phosphorylation of SHP-2. This is consistent with the recent studies by Lu et al. (2001) which suggest that tyrosine phosphorylation of SHP-2 is essential for its activation and is sufficient for the activation of MAPK. While transfection of cells with SHPS-1 mutants inhibited the activation of MAPK and Akt by IL-1b, the Src family kinase inhibitor, PP1, markedly inhibited IL-1b-dependent SHPS-1 tyrosine phosphorylation. SHPS-1 -SHP-2 complex formation and MAPK/Akt phosphorylation. These results strongly suggest the importance of the Src family kinases as an upstream effector of the SHPS-1 -SHP-2 complex in regulating MAPK/Akt activation. In contrast, IL-1b could not induce association of other phosphoproteins like IRS-1 and Gab-1 with SHP-2 in Balb3T3 and Balb3T3 overexpressing ECTM mutant (data not shown), further suggesting the importance of SHPS-1 -SHP-2 complex formation in IL-1b signaling.
IL-1 appears to trigger intracellular signaling cascades by binding IL-1 receptors, type I (BankersFulbright et al., 1996) . When IL-1 binds to IL-1RI, a complex is formed that then binds to the IL-1RAcP resulting in high affinity binding (Greenfeder et al., 1995) . Sizemore et al. (1999) reported that p85 subunit of PI3K formed a complex with a specific region of IL1RAcP and mediated IL-1b-dependent NF-kB activation via Akt. We show that SHPS-1 forms a complex with IL-1RAcP and this complex formation is required, at least in part, for the activation of Akt and Erk by IL-1b. Detailed study is necessary to clarify the basis of this IL-1b-dependent complex formation between SHPS-1 and IL-1RAcP.
